Northwest & Ethical Investments’s Profound Medical PROF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$244K Hold
38,200
0.01% 470
2025
Q4
$300K Hold
38,200
0.01% 445
2025
Q3
$187K Sell
38,200
-8,000
-17% -$40.8K ﹤0.01% 467
2025
Q2
$274K Hold
46,200
0.01% 439
2025
Q1
$265K Hold
46,200
0.01% 433
2024
Q4
$346K Buy
46,200
+22,500
+95% +$173K 0.01% 362
2024
Q3
$189K Hold
23,700
0.01% 421
2024
Q2
$203K Buy
23,700
+6,300
+36% +$50.8K 0.01% 399
2024
Q1
$147K Hold
17,400
﹤0.01% 417
2023
Q4
$146K Buy
+17,400
New +$165K ﹤0.01% 363
2021
Q3
Sell
-2,244
Closed -$36.5K 424
2021
Q2
$36.5K Buy
2,244
+1,494
+199% +$27.8K ﹤0.01% 401
2021
Q1
$15K Buy
750
+34
+5% +$815 ﹤0.01% 404
2020
Q4
$14.7K Buy
+716
New +$13.2K ﹤0.01% 403

Other funds holding PROF

Northwest & Ethical Investments's PROF Position: Q1 2026 in Review

Northwest & Ethical Investments held its Profound Medical (PROF) position steady in Q1 2026 at 38,200 shares worth $244K. The position accounts for 0.01% of the portfolio, ranked #470.

Northwest & Ethical Investments first reported a position in PROF in Q4 2020 and has held it in 13 quarters since. The position peaked at $346K in Q4 2024. 57 funds tracked by Wall St. Rank hold PROF as of Q1 2026.

  • Northwest & Ethical Investments held 38,200 shares of Profound Medical worth $244K as of Q1 2026.
  • Northwest & Ethical Investments left its Profound Medical share count unchanged in Q1 2026.
  • Profound Medical made up 0.01% of Northwest & Ethical Investments's portfolio in Q1 2026, its #470 holding.
  • Northwest & Ethical Investments first reported a position in Profound Medical in Q4 2020 and has held it in 13 quarters since.
  • Northwest & Ethical Investments's Profound Medical position peaked at $346K in Q4 2024.
  • 57 funds tracked by Wall St. Rank held Profound Medical as of Q1 2026.

Based on Northwest & Ethical Investments's 13F filing for Q1 2026, filed 14 May 2026.